ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Zolbetuximab Biosimilar - Anti-Claudin18 Antibody - Low endotoxin, Azide free (A323855)

Recombinant chimeric monoclonal antibody to Claudin18 for ELISA, FACS, Functional Assay and In Vivo.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 12-18 business days.
Name
Zolbetuximab Biosimilar - Anti-Claudin18 Antibody - Low endotoxin, Azide free
Description
Recombinant chimeric monoclonal antibody to Claudin18.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human, Mouse
Host
Chimeric
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 150 kDa.
Purity
> 95% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
Claudin-18, CLDN18
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Zolbetuximab Biosimilar - Anti-Claudin18 Antibody - Low endotoxin, Azide free (A323855)? Please let us know so that we can list the citation on this page.

Alternative products to Zolbetuximab Biosimilar - Anti-Claudin18 Antibody - Low endotoxin, Azide free (A323855)

Proteins predicted to interact with Claudin18

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
83.2% Relevancy Score
83.2% Relevancy Score
82.4% Relevancy Score
82.2% Relevancy Score
79.9% Relevancy Score
77.3% Relevancy Score
77.1% Relevancy Score
75.1% Relevancy Score
74.1% Relevancy Score